Top

Published in:

Open Access 01-07-2020 | Fibromyalgia | Neurological Update

Management of functional neurological disorder

Authors: Gabriela S. Gilmour, Glenn Nielsen, Tiago Teodoro, Mahinda Yogarajah, Jan Adriaan Coebergh, Michael D. Dilley, Davide Martino, Mark J. Edwards

Published in: Journal of Neurology | Issue 7/2020

Abstract

Functional neurological disorder (FND) is a common cause of persistent and disabling neurological symptoms. These symptoms are varied and include abnormal control of movement, episodes of altered awareness resembling epileptic seizures and abnormal sensation and are often comorbid with chronic pain, fatigue and cognitive symptoms. There is increasing evidence for the role of neurologists in both the assessment and management of FND. The aim of this review is to discuss strategies for the management of FND by focusing on the diagnostic discussion and general principles, as well as specific treatment strategies for various FND symptoms, highlighting the role of the neurologist and proposing a structure for an interdisciplinary FND service.

Edwards MJ, Bhatia KP (2012) Functional (psychogenic) movement disorders: merging mind and brain. Lancet Neurol 11:250–260. https://doi.org/10.1016/S1474-4422(11)70310-6 CrossRefPubMed

Stone J (2016) Functional neurological disorders: the neurological assessment as treatment. Pract Neurol 16:7–17. https://doi.org/10.1136/practneurol-2015-001241 CrossRefPubMed

Věchetová G, Růžička E, Nikolai T et al (2018) The impact of non-motor symptoms on the health-related quality of life in patients with functional movement disorders. J Psychosom Res 115:32–37. https://doi.org/10.1016/j.jpsychores.2018.10.001 CrossRefPubMed

Stone J, Edwards MJ (2013) Trick or treat: showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology 79:282–284. https://doi.org/10.1212/WNL.0b013e31825fdf63 CrossRef

Ludwig L, Pasman JA, Nicholson T et al (2018) Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case–control studies. Lancet Psychiatry 5:307–320. https://doi.org/10.1016/S2215-0366(18)30051-8 CrossRefPubMed

Gasparini S, Beghi E, Ferlazzo E et al (2019) Management of psychogenic non-epileptic seizures: a multidisciplinary approach. Eur J Neurol 26:205–213. https://doi.org/10.1111/ene.13818 CrossRefPubMed

Kutlubaev MA, Xu Y, Hackett ML, Stone J (2018) Dual diagnosis of epilepsy and psychogenic nonepileptic seizures: systematic review and meta-analysis of frequency, correlates, and outcomes. Epilepsy Behav 89:70–78. https://doi.org/10.1016/j.yebeh.2018.10.010 CrossRefPubMed

Kroenke K, Spitzer RL, Williams JBW (2001) The patient health questionnaire-9: validity of a brief depression severity measure. J Gen Intern Med 16:606–613. https://doi.org/10.1097/01.mlr.0000093487.78664.3c CrossRefPubMedPubMedCentral

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x CrossRefPubMed

10.

Sptizer RL, Kroenke K, Williams JBW, Lowe B (2006) A brief measure for assessing generalized anxiety disorder. Arch Intern Med 166:1092–1097. https://doi.org/10.1001/archinte.166.10.1092 CrossRef

11.

National Institute for Health and Care Excellence (2018) Depression in adults: recognition and management (NICE Guideline 90), pp 1–53

12.

National Institute for Health and Care Excellence (2011) Generalised anxiety disorder and panic disorder in adults: management (NICE Guideline 113), pp 1–41

13.

Brough JL, Moghaddam NG, Gresswell DM, Dawson DL (2015) The impact of receiving a diagnosis of non-epileptic attack disorder (NEAD): a systematic review. J Psychosom Res 79:420–427. https://doi.org/10.1016/j.jpsychores.2015.09.009 CrossRefPubMed

14.

Gelauff J, Stone J, Edwards M, Carson A (2014) The prognosis of psychogenic (functional) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry 85:220–226. https://doi.org/10.1136/jnnp-2013-305321 CrossRefPubMed

15.

Nielsen G, Stone J, Matthews A et al (2015) Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry 86:1113–1119. https://doi.org/10.1136/jnnp-2014-309255 CrossRefPubMed

16.

Nielsen G, Buszewicz M, Stevenson F et al (2017) Randomised feasibility study of physiotherapy for patients with functional motor symptoms. J Neurol Neurosurg Psychiatry 88:484–490. https://doi.org/10.1136/jnnp-2016-314408 CrossRefPubMed

17.

Nielsen G (2016) Chapter 45—Physical treatment of functional neurologic disorders. In: Hallett M, Stone J, Carson A (eds) Functional Neurologic Disorders. Elsevier, Oxford, pp 555–569CrossRef

18.

Demartini B, Batla A, Petrochilos P et al (2014) Multidisciplinary treatment for functional neurological symptoms: a prospective study. J Neurol 261:2370–2377. https://doi.org/10.1007/s00415-014-7495-4 CrossRefPubMedPubMedCentral

19.

Jordbru AA, Smedstad LM, Klungsoyr O, Martinsen EW (2014) Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med 46:181–187. https://doi.org/10.2340/16501977-1246 CrossRefPubMed

20.

McCormack R, Moriarty J, Mellers JD et al (2014) Specialist inpatient treatment for severe motor conversion disorder: a retrospective comparative study. J Neurol Neurosurg Psychiatry 85:893–898. https://doi.org/10.1136/jnnp-2013-305716 CrossRef

21.

Maggio JB, Ospina JP, Callahan J et al (2020) Outpatient physical therapy for functional neurological disorder: a preliminary feasibility and naturalistic outcome study in a U.S. cohort. J Neuropsychiatry Clin Neurosci 32:85–89. https://doi.org/10.1176/appi.neuropsych.19030068 CrossRefPubMed

22.

Howlett S, Reuber M (2009) An augmented model of brief psychodynamic interpersonal therapy for patients with nonepileptic seizures. Psychother Theory, Res Pract Train 46:125–138. https://doi.org/10.1037/a0015138 CrossRef

23.

Rockliffe-Fidler C, Willis M (2019) Explaining dissociative seizures: a neuropsychological perspective. Pract Neurol 19:259–263. https://doi.org/10.1136/practneurol-2018-002100 CrossRefPubMed

24.

Lafrance WC, Reuber M, Goldstein LH (2013) Management of psychogenic nonepileptic seizures. Epilepsia 54:53–67. https://doi.org/10.1111/epi.12106 CrossRefPubMed

25.

Jayne M, Jennifer P, Marson AG (2014) Psychological and behavioural treatments for adults with non-epileptic attack disorder. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006370.pub2 CrossRef

26.

Cope SR, Smith JG, King T, Agrawal N (2017) Evaluation of a pilot innovative cognitive-behavioral therapy-based psychoeducation group treatment for functional non-epileptic attacks. Epilepsy Behav 70:238–244. https://doi.org/10.1016/j.yebeh.2017.02.014 CrossRefPubMed

27.

Fiszman A, Alves-Leon SV, Nunes RG et al (2004) Traumatic events and posttraumatic stress disorder in patients with psychogenic nonepileptic seizures: a critical review. Epilepsy Behav 5:818–825. https://doi.org/10.1016/j.yebeh.2004.09.002 CrossRefPubMed

28.

Reuber M (2009) The etiology of psychogenic non-epileptic seizures: toward a biopsychosocial model. Neurol Clin 27:909–924. https://doi.org/10.1016/j.ncl.2009.06.004 CrossRefPubMed

29.

LaFrance WC, Baird GL, Barry JJ et al (2014) Multicenter pilot treatment trial for psychogenic nonepileptic seizures. JAMA Psychiatry 71:997–1005. https://doi.org/10.1001/jamapsychiatry.2014.817 CrossRefPubMed

30.

Pennington C, Newson M, Hayre A, Coulthard E (2015) Functional cognitive disorder: what is it and what to do about it? Pract Neurol 15:436–444. https://doi.org/10.1136/practneurol-2015-001127 CrossRefPubMed

31.

Stone J, Pal S, Blackburn D et al (2015) Functional (psychogenic) cognitive disorders: a perspective from the neurology clinic. J Alzheimer’s Dis 48:S5–S17. https://doi.org/10.3233/jad-150430 CrossRef

32.

Metternich B, Schmidtke K, Dykierek P, Hüll M (2008) A pilot group therapy for functional memory disorder. Psychother Psychosom 77:259–260. https://doi.org/10.1159/000128166 CrossRefPubMed

33.

Stone J, Sharpe M, Rothwell PM, Warlow CP (2003) The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 74:591–596. https://doi.org/10.1136/jnnp.74.5.591 CrossRefPubMedPubMedCentral

34.

Yeo JM, Carson A, Stone J (2019) Seeing again: treatment of functional visual loss. Pract Neurol 19:168–172. https://doi.org/10.1136/practneurol-2018-002092 CrossRefPubMed

35.

Parain D, Chastan N (2014) Large-field repetitive transcranial magnetic stimulation with circular coil in the treatment of functional neurological symptoms. Neurophysiol Clin 44:425–431. https://doi.org/10.1016/j.neucli.2014.04.004 CrossRefPubMed

36.

Hallett M, Stone J, Carson A (2018) Functional neurologic disorders. Handb Clin Neurol 139:1–641

37.

Hoertizauer I, Stone J, Fowler C et al (2016) Fowler’s syndrome of urinary retention: a retrospective study of co-morbidity. Neurourol Urodyn 35:601–603. https://doi.org/10.1002/nau.22758 CrossRef

38.

Dasgupta R, Wiseman OJ, Kitchen N, Fowler CJ (2004) Long-term results of sacral neuromodulation for women with urinary retention. BJU Int 94:335–337. https://doi.org/10.1111/j.1464-410X.2004.04979.x CrossRefPubMed

39.

Thompson KJ, Goetting JC, Staab JP, Shepard NT (2015) Retrospective review and telephone follow-up to evaluate a physical therapy protocol for treating persistent postural-perceptual dizziness: a pilot study. J Vestib Res Equilib Orientat 25:97–104. https://doi.org/10.3233/VES-150551 CrossRef

40.

Popkirov S, Staab JP, Stone J (2018) Persistent postural–perceptual dizziness (PPPD): a common, characteristic and treatable cause of chronic dizziness. Pract Neurol 18:5–13. https://doi.org/10.1136/practneurol-2017-001809 CrossRefPubMed

41.

Baizabal-Carvallo JF, Jankovic J (2015) Speech and voice disorders in patients with psychogenic movement disorders. J Neurol 262:2420–2424. https://doi.org/10.1007/s00415-015-7856-7 CrossRefPubMed

42.

Reiter R, Rommel D, Brosch S (2013) Long term outcome of psychogenic voice disorders. Auris Nasus Larynx 40:470–475. https://doi.org/10.1016/j.anl.2013.01.002 CrossRefPubMed

43.

Galmiche JP, Clouse RE, Balint A et al (2006) Functional esophageal disorders. Gastroenterology 130:1459–1465. https://doi.org/10.1053/j.gastro.2005.08.060 CrossRefPubMed

44.

Khalil HS, Reddy VM, Bos-Clark M et al (2011) Speech therapy in the treatment of globus pharyngeus: how we do it. Clin Otolaryngol 36:388–392. https://doi.org/10.1111/j.1749-4486.2011.02326.x CrossRefPubMed

45.

Stone J, Warlow C, Sharpe M (2010) The symptom of functional weakness: a controlled study of 107 patients. Brain 133:1537–1551. https://doi.org/10.1093/brain/awq068 CrossRefPubMed

46.

Benbadis SR (2005) A spell in the epilepsy clinic and a history of “chronic pain” or “fibromyalgia” independently predict a diagnosis of psychogenic seizures. Epilepsy Behav 6:264–265. https://doi.org/10.1016/j.yebeh.2004.12.007 CrossRefPubMed

47.

Gazzola DM, Carlson C, Rugino A et al (2012) Psychogenic nonepileptic seizures and chronic pain: a retrospective case-controlled study. Epilepsy Behav 25:662–665. https://doi.org/10.1016/j.yebeh.2012.10.008 CrossRefPubMed

48.

Teodoro T, Edwards MJ, Isaacs JD (2018) A unifying theory for cognitive abnormalities in functional neurological disorders, fibromyalgia and chronic fatigue syndrome: systematic review. J Neurol Neurosurg Psychiatry 89:1308–1319. https://doi.org/10.1136/jnnp-2017-317823 CrossRefPubMed

49.

Price JR, Mitchell E, Tidy E, Hunot V (2010) Cognitive behaviour therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD001027.pub2 CrossRefPubMed

50.

Galeoto G, Sansoni J, Valenti D et al (2008) The effect of physiotherapy on fatigue and physical functioning in chronic fatigue syndrome patients: a systematic review. Clin Ther 169:e184–188. https://doi.org/10.7417/T.2018.2076 CrossRef

51.

Larun L, Brurberg KG, Odgaard-Jensen J, Price JR (2007) Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003200.pub7 CrossRef

52.

Collatz A, Johnston SC, Staines DR, Marshall-Gradisnik SM (2016) A systematic review of drug therapies for chronic fatigue syndrome/myalgic encephalomyelitis. Clin Ther 38:1263–1271. https://doi.org/10.1016/j.clinthera.2016.04.038 CrossRefPubMed

53.

Bernardy K, Klose P, Welsch P, Häuser W (2018) Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome—a systematic review and meta-analysis of randomized controlled trials. Eur J Pain 22:242–260. https://doi.org/10.1002/ejp.1121 CrossRefPubMed

54.

Sosa-Reina MD, Nunez-Nagy S, Gallego-Izquierdo T et al (2017) Effectiveness of therapeutic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomized clinical trials. Biomed Res Int 2017:1–14. https://doi.org/10.1155/2017/2356346 CrossRef

55.

Derry S, Cording M, Wiffen PJ et al (2017) Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD011790.pub2 CrossRefPubMedPubMedCentral

56.

Cooper TE, Derry S, Wiffen PJ, Moore RA (2017) Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012188.pub2 CrossRefPubMedPubMedCentral

57.

Lian YN, Wang Y, Zhang Y, Yang CX (2020) Duloxetine for pain in fibromyalgia in adults: a systematic review and a meta-analysis. Int J Neurosci 130:71–82. https://doi.org/10.1080/00207454.2019.1664510 CrossRefPubMed

58.

Caumo W, Deitos A, Carvalho S et al (2016) Motor cortex excitability and BDNF levels in chronic musculoskeletal pain according to structural pathology. Front Hum Neurosci 10:357. https://doi.org/10.3389/fnhum.2016.00357 CrossRefPubMedPubMedCentral

59.

Kösehasanoğullari M, Erdinç Gündüz N, Akalin E (2019) Is fibromyalgia syndrome a neuropathic pain syndrome? Arch Rheumatol 34:196–203. https://doi.org/10.5606/ArchRheumatol.2019.7244 CrossRefPubMed

60.

Deitos A, Soldatelli MD, Dussán-Sarria JA et al (2018) Novel insights of effects of pregabalin on neural mechanisms of intracortical disinhibition in physiopathology of fibromyalgia: an explanatory, randomized, double-blind crossover study. Front Hum Neurosci 12:1–14. https://doi.org/10.3389/fnhum.2018.00406 CrossRef

61.

Hunter AM, Leuchter AF, Cook IA et al (2009) Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Med 10:730–738. https://doi.org/10.1111/j.1526-4637.2009.00614.x CrossRefPubMed

62.

Gilron I, Chaparro LE, Tu D et al (2016) Combination of pregabalin with duloxetine for fibromyalgia. Pain 157:1532–1540. https://doi.org/10.1097/j.pain.0000000000000558 CrossRefPubMed

63.

Hou WH, Wang TY, Kang JH (2016) The effects of add-on non-invasive brain stimulation in fibromyalgia: a meta-analysis and meta-regression of randomized controlled trials. Rheumatol (United Kingdom) 55:1507–1517. https://doi.org/10.1093/rheumatology/kew205 CrossRef

64.

Dailey DL, Vance CG, Rakel BA, et al (2019) A randomized controlled trial of TENS for movement‐evoked pain in women with fibromyalgia

65.

Elliott JO, Charyton C (2014) Biopsychosocial predictors of psychogenic non-epileptic seizures. Epilepsy Res 108:1543–1553. https://doi.org/10.1016/j.eplepsyres.2014.09.003 CrossRefPubMed

66.

NHS Scotland (2012) Stepped care for functional neurological symptoms. Healthc Improv Scotl 20:20

67.

Jacob AE, Smith CA, Jablonski ME et al (2018) Multidisciplinary clinic for functional movement disorders (FMD): 1-year experience from a single centre. J Neurol Neurosurg Psychiatry 89:1011–1012. https://doi.org/10.1136/jnnp-2017-316523 CrossRefPubMed

Title: Management of functional neurological disorder
Authors: Gabriela S. Gilmour
Glenn Nielsen
Tiago Teodoro
Mahinda Yogarajah
Jan Adriaan Coebergh
Michael D. Dilley
Davide Martino
Mark J. Edwards
Publication date: 01-07-2020
Publisher: Springer Berlin Heidelberg
Keywords: Fibromyalgia
Fibromyalgia
Movement Disorder
Fatigue
Published in: Journal of Neurology / Issue 7/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-020-09772-w

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Management of functional neurological disorder

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2020

Guillain-Barré syndrome following COVID-19: new infection, old complication?

Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group

Genetic correlations and causal inferences in ischemic stroke

Idiopathic RBD: the role of gender

The etiology of Bell’s palsy: a review

Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease